Wegener's granulomatosis: Role of environmental exposures

Clinical and Experimental Rheumatology

Volumn 16, Issue 6, 1998, Pages 669-674

  Duna, G F ^a   Cotch, M F ^b   Galperin, C ^a   Hoffman, D B ^a,b   Hoffman, G S ^a,b  

^a LERNER RESEARCH INSTITUTE   (United States)

^b NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

Epidemiology; Host susceptibility; Inhalants; Wegener's granulomatosis

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CONTROLLED STUDY; ENVIRONMENTAL EXPOSURE; FEMALE; FUME; HOST SUSCEPTIBILITY; HUMAN; INFLAMMATION; LUNG ALVEOLITIS; MAJOR CLINICAL STUDY; MALE; NECROTIZING ARTERITIS; PARTICULATE MATTER; PRIORITY JOURNAL; SCHOOL CHILD; SEASONAL VARIATION; WEGENER GRANULOMATOSIS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; AIR POLLUTANTS; CASE-CONTROL STUDIES; CHILD; DISEASE SUSCEPTIBILITY; FEMALE; HUMANS; INHALATION EXPOSURE; MALE; MARYLAND; MIDDLE AGED; OHIO; PULMONARY FIBROSIS; QUESTIONNAIRES; RHEUMATIC DISEASES; SARCOIDOSIS, PULMONARY; SEASONS; SELF DISCLOSURE; WEGENER GRANULOMATOSIS;

EID: 0031790105     PISSN: 0392856X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. LEAVITT RY, FAUCI AS, BLOCH DA et al.: The American College of Rheumatology 1990 criteria for the classification of Wegener's granulomatosis. Arthritis Rheum 1990; 33: 1101-7.
2. HOFFMAN GS, KERR GS, LEAVITT RY et al.: Wegener granulomatosis: An analysis of 158 patients. Ann Intern Med 1992; 116: 488-98.
3. COTCH MF, HOFFMAN GS, YERG DE, KAUFMAN GI, TARGONSKI P, KASLOW RA: The epidemiology of Wegener's granulomatosis: Estimates of the five-year period prevalence, annual mortality, and geographic disease distribution from population-based data sources. Arthritis Rheum 1996; 39: 87-92.
4. HOFFMAN GS, SECHLER JMG, GALLIN JI et al.: Bronchoalveolar lavage analysis in Wegener's granulomatosis. Am Rev Respir Dis 1991; 143: 401-7.
5. HOFFMAN GS: Wegener's granulomatosis. Curr Opin Rheumatol 1993; 5: 11-7.
6. RAYNAULD JP, BLOCK DA, FRIES JF: Seasonal variation in the onset of Wegener's granulomatosis, polyarteritis nodosa, and giant cell arteritis. J Rheumatol 1993; 20: 1524-1526.
7. FALK JR, HOGAN S, CAREY TS, JENNETTE JC: The clinical course of patients with antineutrophil cytoplasmic autoantibody associated glomerulonephritis and systemic vasculitis. Ann Intern Med 1990; 113: 656-63.
8. NUYTS GD, VAN VLEM E, DE VOS A et al.: Wegener granulomatosis is associated to exposure to silicon compounds: A case-control study. Nephrol Dial Transplant 1995; 10: 1162-5.
9. NEYER U, WOSS E, NEUWEILER J: Wegener's granulomatosis associated with silicosis. Nephrol Dial Transplant 1994; 9: 559-61.
10. BALTARO RJ, HOFFMAN GS, SECHLER JMG et al: Immunoglobulin G antineutrophil cytoplasmic antibodies are produced in the respiratory tract of patients with Wegener's granulomatosis. Am Rev Respir Dis 1991; 143: 275-8.
11. SPECKS U, WHEATLEY CL, MCDONALD TJ et al.: Anticytoplasmic autoantibodies in the diagnosis and followup of Wegener's granulomatosis. Mayo Clin Proc 1989; 64: 28-36.
12. HAUSCHILD S, SCHMITT W, CSERNOK E, FLESCH BK, RAUTMANN A, GROSS WL: ANCA in systemic vasculitides, collagen vascular diseases, rheumatic disorders and inflammatory bowel diseases. In GROSS WL (Ed.): ANCA-Associated Vasculitides. New York, Plenum Press 1993; 245-51.
13. HAGEN EC, DAHA MR, HERMANS J et al.: Diagnostic value of standardized assays for antineutrophil cytoplasmic antibodies in idiopathic systemic vasculitis. Kidney Int 1998; 53: 743-53.
14. HAGEN EC, BALLIEUX BEPB, DAHA MR, VAN ES LA, VAN DER WOUDE FJ: Fundamental and clinical aspects of antineutrophil cytoplasmic antibodies. Autoimmunity 1992; 11: 199-207.
15. ROTTEM M, FAUCI AS, HALLAHAN CWet al.: Wegener's granulomatosis in children and adolescents: Clinical presentation and outcome. J Pediatr 1993; 122: 26-31.